Italian agency threatens action over drug shortages due to parallel trade
This article was originally published in Scrip
The Italian regulatory agency AIFA has warned that it intends to clamp down on companies and wholesalers whose parallel exporting activity is found to be causing product shortages, after the pharmacist association Federfarma told the agency the lack of certain medicines on the Italian market was leading to "serious risks" to health.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.